IGFBP2 and hemolytic-uremic syndrome: In the present study, we measured serum IGFBP2 levels in patients with HUS and assessed the correlation of serum IGFBP2 levels with measures of disease activity and severity, with the aim to elucidate its clinical relevance in these patients.